VIVAN Therapeutics
London
About VIVAN Therapeutics
VIVAN Therapeutics, a company pioneering personalized cancer therapeutics using a new assay technology. MPT licensed technology from the Center for Personalized Cancer Therapeutics at Mt Sinai New York and is launching the world’s most comprehensive, personal genomics-based, block-chain enabled drug screening service. All recommended treatment combinations will include a cancer drug and a non cancer drug, making treatments less toxic and more affordable. Intelligently designed personalized treatment. Revolutionary cancer care.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.6M
- Funding stage: Seed
- Last round: Grant (Dec 2022)
- Website: vivantx.com
- Phone: [email protected]
Industries & Categories
Big Data, Biotechnology, Health Care, Health Diagnostics, Oncology
Social Profiles
Canonical: https://fsome.com/organization/vivan-therapeutics-68885 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.